🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to see if Pembrolizumab in combination wi...
Status
Active Not Recruiting
Location
Indiana University
Start Date
2016-05-31
Trial ID
NCT02755272
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
This study is a multi-center, randomized, open label, Phase III clinical tr...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2014-07
Trial ID
NCT02578641
This multicenter study will assess the efficacy and safety of bevacizumab i...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01201265
Treatments Being Tested
Triple negative breast cancer (TNBC) represents approximately 15% of all br...
Status
Completed
Location
Hospital Universitario Virgen de las Nieves
Start Date
2022-01-11
Trial ID
NCT05181462
Treatments Being Tested
Primary Objective: * To assess the safety and the maximum tolerated dose(M...
Status
Completed
Location
Investigational Site Number 840002
Start Date
2011-11
Trial ID
NCT01455532
Treatments Being Tested
This was a study to investigate the potential clinical benefit of trilacicl...
Status
Terminated
Location
Arizona Oncology Associates, PC - HOPE
Start Date
2017-02-02
Trial ID
NCT02978716
Treatments Being Tested
Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Ne...
Status
Unknown
Location
Fudan University Cancer Hospital
Start Date
2015-01
Trial ID
NCT02341911
Treatments Being Tested
P276-00 is a novel, potent, small-molecule, flavone-derived Cdk 4 D1, Cdk1 ...
Status
Terminated
Location
Disney Cancer Center
Start Date
2011-08
Trial ID
NCT01333137
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy of nab-pacl...
Status
Completed
Location
Ironwood Cancer and Research Center
Start Date
2013-09-26
Trial ID
NCT01881230
Treatments Being Tested